Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Management of HER2-Positive Early Breast Cancer.
2018
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Vienna, Austria.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Advances in the management of HER2-positive early breast cancer.
November 2017, Critical reviews in oncology/hematology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Management of hormone receptor-positive, HER2-negative early breast cancer.
August 2020, Seminars in oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Optimizing the management of HER2-positive early breast cancer: the clinical reality.
August 2010, Current oncology (Toronto, Ont.),
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
The management of HER2-positive early breast cancer: Current and future therapies.
September 2021, Asia-Pacific journal of clinical oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Endpoint selection in HER2-positive early breast cancer.
March 2019, The Lancet. Oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Adjuvant trastuzumab for HER2-positive early breast cancer.
June 2010, Clinical journal of oncology nursing,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Neoadjuvant pertuzumab in early HER2-positive breast cancer.
December 2013, Clinical advances in hematology & oncology : H&O,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer.
January 2018, South Asian journal of cancer,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Breast cancer: Increasing therapy options for HER2-positive early breast cancer.
December 2011, Nature reviews. Clinical oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer.
January 2022, Therapeutic advances in medical oncology,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name